Provention Bio, Inc.

Bank of New York Mellon Corp

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/9/2023

Shares

225,493

Value ($000)

5,434

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/9/2023	5,434	0.0%	225,493	3/31/2023
2022 Q4	2/14/2023	2,802	0.0%	265,132	12/31/2022
2022 Q3	11/14/2022	963	0.0%	214,030	9/30/2022
2022 Q2	8/15/2022	690	0.0%	172,358	6/30/2022
2022 Q1	5/11/2022	1,500	0.0%	204,913	3/31/2022
2021 Q4	2/11/2022	1,212	0.0%	215,763	12/31/2021
2021 Q3	11/18/2021	1,463	0.0%	228,569	9/30/2021
2021 Q2	8/11/2021	1,667	0.0%	197,799	6/30/2021
2021 Q1	5/13/2021	1,890	0.0%	180,029	3/31/2021
2020 Q4	2/9/2021	2,992	0.0%	176,639	12/31/2020
2020 Q3	11/12/2020	2,201	0.0%	171,516	9/30/2020
2020 Q2	8/12/2020	2,274	0.0%	161,172	6/30/2020
2020 Q1	5/6/2020	207	0.0%	22,506	3/31/2020
2019 Q4	2/14/2020	708	0.0%	47,506	12/31/2019